Artificial Intelligence is constantly in the news, with applications from self-driving cars, healthcare, share-trading, and law. There are also many applications in drug discovery and development, and the promise of the field has led to the formation of many new AI companies, formation of AI groups at large pharma and significant financial investment in the field. Automated drug design, drug repurposing and retrosynthesis are just a few of the specific application areas of AI. But how does the reality match the hype. The meeting brings together recognised experts to provide a realistic view and discuss the likely future of AI in Drug Discovery.